• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Heart J . Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study

tetano

Editor, Senior Moderator
Eur Heart J


. 2020 Sep 24;ehaa664.
doi: 10.1093/eurheartj/ehaa664. Online ahead of print.
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study


Cristina Basso[SUP] 1 [/SUP], Ornella Leone[SUP] 2 [/SUP], Stefania Rizzo[SUP] 1 [/SUP], Monica De Gaspari[SUP] 1 [/SUP], Allard C van der Wal[SUP] 3 [/SUP], Marie-Christine Aubry[SUP] 4 [/SUP], Melanie C Bois[SUP] 4 [/SUP], Peter T Lin[SUP] 4 [/SUP], Joseph J Maleszewski[SUP] 4 [/SUP], James R Stone[SUP] 5 [/SUP]



Affiliations

Abstract

Aims: Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been associated with cardiovascular features of myocardial involvement including elevated serum troponin levels and acute heart failure with reduced ejection fraction. The cardiac pathological changes in these patients with COVID-19 have yet to be well described.
Methods and results: In an international multicentre study, cardiac tissue from the autopsies of 21 consecutive COVID-19 patients was assessed by cardiovascular pathologists. The presence of myocarditis, as defined by the presence of multiple foci of inflammation with associated myocyte injury, was determined, and the inflammatory cell composition analysed by immunohistochemistry. Other forms of acute myocyte injury and inflammation were also described, as well as coronary artery, endocardium, and pericardium involvement. Lymphocytic myocarditis was present in 3 (14%) of the cases. In two of these cases, the T lymphocytes were CD4 predominant and in one case the T lymphocytes were CD8 predominant. Increased interstitial macrophage infiltration was present in 18 (86%) of the cases. A mild pericarditis was present in four cases. Acute myocyte injury in the right ventricle, most probably due to strain/overload, was present in four cases. There was a non-significant trend toward higher serum troponin levels in the patients with myocarditis compared with those without myocarditis. Disrupted coronary artery plaques, coronary artery aneurysms, and large pulmonary emboli were not identified.
Conclusions: In SARS-CoV-2 there are increased interstitial macrophages in a majority of the cases and multifocal lymphocytic myocarditis in a small fraction of the cases. Other forms of myocardial injury are also present in these patients. The macrophage infiltration may reflect underlying diseases rather than COVID-19.

Keywords: Autopsy; COVID-19; Heart; Macrophages; Myocarditis; Myocardium; SARS; SARS-CoV-2.
 
Back
Top Bottom